Consistent with previous studies (Santangelo et al., 2017), our previous meta-analysis also showed the comparatively lower CSF Aβ1–42, T-tau, and p-tau levels in patients with NPH compared with patients with AD (Chen et al., 2017). Here, MAPT is linked to Alzheimer disease.